Maurizio Ghisoli
Texas Oncology(US)Medical City Children's Hospital(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, CAR-T cell therapy research, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma(2016)94 cited
- → Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma(2015)53 cited
- → Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma(2016)42 cited
- → The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastoma(2010)40 cited
- → Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA(2023)21 cited
- → Case Report: Immune-mediated Complete Response in a Patient With Recurrent Advanced Ewing Sarcoma (EWS) After Vigil Immunotherapy(2017)16 cited
- → Mixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV(2020)12 cited
- → Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy(2024)5 cited
- → Pilot trial of vigil immunotherapy in Ewing’s sarcoma.(2015)4 cited
- → Multidisciplinary Management of Retinoblastoma: Diagnosis, Treatment, and Future Direction(2010)2 cited